An image showing the words 'latest updates'

New investigation looks at the procurement, usability and adoption of ‘smart’ pumps

by Communications team

HSIB have launched an investigation after being notified of three incidents where an accidental fentanyl overdose occurred. The Trust had administered the powerful pain medication using a ‘smart’ infusion device.

‘Smart’ infusion devices (or smart pumps) are used when administering intravenous medication (drugs that go directly into a vein). They have built-in ‘dose error reduction’ software that aims to reduce the likelihood of patient harm if the device is setup incorrectly.

Initial research carried out by the HSIB investigation team suggests that it may be challenging to integrate or replace current systems used to administer intravenous medication in NHS trusts.

The investigation will examine the current procurement, usability and adoption of the smart pumps, and look at what might be needed to introduce smart pumps effectively in trusts across England.

Follow progress on this investigation

Please contact to register for email updates on this investigation.

You can also follow progress on the smart pumps investigation page.

Back to news

Related news

A nurse presses a button on a patient monitor in a critical care unit.

New report charts brain injury risk of critical care blood sampling system

Read news article
Maternity year in review 2021/22

Future name announced as we reflect on past achievements of our maternity programme

Read news article
Introducing Dr Rosie Benneyworth, interim Chief Investigator.

HSIB’s new interim Chief Investigator focused on ‘maximum impact’ patient safety

Read news article
Family comforting each other.

Integrating restorative justice into patient safety investigation

Read news article
HSIB logo

Dr Rosie Benneyworth appointed interim Chief Investigator

Read news article